» Articles » PMID: 25979962

Metachronous Multicentric Giant Cell Tumour in a Young Woman

Overview
Journal BMJ Case Rep
Specialty General Medicine
Date 2015 May 17
PMID 25979962
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Multicentric giant cell tumours (GCTs) are very rare and account for less than 1% of all GCTs of bone. We report a case of a young woman with metachronous multicentric GCTs with 5 documented lesions in the same lower limb. The initial lesion started during the first trimester of pregnancy around her right pelvis, which rapidly progressed as a painful swelling with gradually restricted mobility of her right hip joint. The radiological appearance of this tumour was that of a GCT and biopsy confirmed the diagnosis. The role of positron emission tomography (PET) has been highlighted to detect occult lesions. A possible hormonal correlation for these tumours has been discussed. The patient was managed successfully by an aggressive surgical approach for knee and talar lesions, whereas repeated embolisation and denosumab injections were given to treat her pelvic lesion.

Citing Articles

Multidisciplinary marvel: surgical management of aggressive giant cell tumor around the knee in pregnancy: a case report.

Ali A, Sahito B, Irfan S, Farooq Z, Ali S, Iqbal J J Surg Case Rep. 2025; 2025(2):rjaf035.

PMID: 39911763 PMC: 11794448. DOI: 10.1093/jscr/rjaf035.


Measurable progression of giant cell tumour of bone associated with pregnancy - A tertiary sarcoma centre analysis.

Henderson R, Shirodkar K, Hussein M, Jenko N, Jeys L, Botchu R J Clin Orthop Trauma. 2024; 59:102825.

PMID: 39650720 PMC: 11617685. DOI: 10.1016/j.jcot.2024.102825.


Denosumab for an inoperable giant cell tumour of the ischial bone.

Paul A, See L, Ohn M, Ohn K BMJ Case Rep. 2023; 16(12).

PMID: 38110341 DOI: 10.1136/bcr-2023-257619.


Denosumab for Effective Tumor Size Reduction in Patients With Giant Cell Tumors of the Bone: A Systematic Review and Meta-Analysis.

Yayan J Cancer Control. 2020; 27(3):1073274820934822.

PMID: 32869648 PMC: 7710399. DOI: 10.1177/1073274820934822.


Comorbidities and Pregnancy Do Not Affect Local Recurrence in Patients With Giant Cell Tumour of Bone.

Howard E, Gregory J, Tsoi K, Evans S, Flanagan A, Cool P Cureus. 2020; 12(7):e9164.

PMID: 32802601 PMC: 7419151. DOI: 10.7759/cureus.9164.


References
1.
GOLDENBERG R, Campbell C, Bonfiglio M . Giant-cell tumor of bone. An analysis of two hundred and eighteen cases. J Bone Joint Surg Am. 1970; 52(4):619-64. View

2.
Park I, Jeon I . Multicentric giant cell tumor of bone: ten lesions at presentation. Skeletal Radiol. 2003; 32(9):526-9. DOI: 10.1007/s00256-003-0658-5. View

3.
Kaiser R . [On the change in the estrogen/pregnandiol ratios during pregnancy]. Arch Gynakol. 1960; 192:428-36. DOI: 10.1007/BF00669896. View

4.
Oursler M, Pederson L, Fitzpatrick L, Riggs B, Spelsberg T . Human giant cell tumors of the bone (osteoclastomas) are estrogen target cells. Proc Natl Acad Sci U S A. 1994; 91(12):5227-31. PMC: 43967. DOI: 10.1073/pnas.91.12.5227. View

5.
Manaster B, Doyle A . Giant cell tumors of bone. Radiol Clin North Am. 1993; 31(2):299-323. View